Insights
Search Results
Newsletters
6.03.26
The Life Sciences Report – June 2026
This latest edition features articles on accelerating new therapies under the new FDA administration, cash-pay healthcare companies possibly facing kickback and fee-splitting risk under federal and state laws, building in-house legal teams for biotech, digital health, and medical devices companies, and life sciences venture financings for firm clients across 1H2025 and 2H2025.
Client Highlights
6.03.26
Wilson Sonsini Advises Asana on Acquisition of StackAI
On May 28, 2026, Asana, Inc., the operating system for human-agent teams, announced that it has completed the acquisition of StackAI, a no-code AI workflow platform that enables companies to design, test, deploy, and govern custom AI agents and intelligent automation of business-critical workflows. Wilson Sonsini Goodrich & Rosati advised Asana on the transaction.
The StackAI platform connects workflows, data, and actions across enterprise systems such as ERP, CRM, and ITSM to automate operational processes like customer support, IT service requests, compliance workflows, and broader cross-functional business operations. Based in San Francisco, the company has built an impressive track record with customers across financial services, healthcare, and professional services—industries that demand the highest security, reliability, and enterprise-grade governance. Bringing StackAI and Asana together pairs cross-system execution with the platform where teams already plan and run their work alongside the context, ownership, and history of every project.
The Wilson Sonsini team that advised Asana on the transaction was led by Rich Mullen and Kaleigh Hawkins-Schulz and also included:
The StackAI platform connects workflows, data, and actions across enterprise systems such as ERP, CRM, and ITSM to automate operational processes like customer support, IT service requests, compliance workflows, and broader cross-functional business operations. Based in San Francisco, the company has built an impressive track record with customers across financial services, healthcare, and professional services—industries that demand the highest security, reliability, and enterprise-grade governance. Bringing StackAI and Asana together pairs cross-system execution with the platform where teams already plan and run their work alongside the context, ownership, and history of every project.
The Wilson Sonsini team that advised Asana on the transaction was led by Rich Mullen and Kaleigh Hawkins-Schulz and also included:
Client Highlights
6.03.26
Wilson Sonsini Advises Isomorphic Labs on $2.1 Billion Series B Investment Round
On May 12, 2026, Isomorphic Labs, an AI-first drug design and development company, announced it has raised $2.1 billion in Series B funding. The financing round is led by Thrive Capital, and includes participation from existing backers Alphabet and GV alongside new investors MGX, Temasek, CapitalG, and the UK Sovereign AI Fund, significantly expanding Isomorphic Labs’ global capital base. Wilson Sonsini Goodrich & Rosati advised Isomorphic Labs on the transaction.
Client Highlights
6.03.26
Wilson Sonsini Advises Luminopia on Licensing Agreement with ROHTO
On June 2, 2026, Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, announced its first international licensing agreement with ROHTO Pharmaceutical Co., LTD, a Japanese multinational corporation specializing in consumer products and pharmaceuticals. Wilson Sonsini Goodrich & Rosati advised Luminopia on the transaction.
Client Highlights
6.02.26
Firm Advises Noctrix on Acquisition by Resmed
On June 1, 2026, Resmed, a medical device company that develops, manufactures, and distributes medical equipment for the diagnosis, treatment, and management of respiratory disorders, announced it has closed on its acquisition of Noctrix Health, a medical device company that developed and manufactures a novel therapy to treat drug-refractory Restless Legs Syndrome (RLS) for $340 million. Wilson Sonsini Goodrich & Rosati advised Noctrix on the transaction.
Blog Posts
6.02.26
SEC Chairman Invites Comment on Modernizing the IPO Process
In remarks delivered on May 26, 2026, at the Stanford Rock Center for Corporate Governance, SEC Chairman Paul S. Atkins expressly invited public input on how the Commission should improve and modernize the IPO process. The remarks indicate that the Commission is prepared to consider whether long-standing rules governing offering communications, routes to the public markets, and disclosure obligations continue to serve capital formation efficiently in the current market environment. The SEC has provided an online form for submission of comments, and Chairman Atkins requested that any comments be submitted by July 27, 2026.
Newsletters
6.02.26
The Entrepreneurs Report – Q1 2026
Wilson Sonsini is pleased to present the Q1 2026 edition of The Entrepreneurs Report. We’ve compiled a range of data on venture, convertible note, and SAFE financing transactions in which the firm was involved during the first quarter, with the objective of identifying relevant trends in activity and valuation levels for the U.S. venture capital industry in general.
Client Highlights
6.02.26
Wilson Sonsini Advises Centerview as Financial Advisor to Motorola Solutions in D-Fend Solutions Acquisition
On June 1, 2026, Motorola Solutions announced that it has entered into a definitive agreement to acquire D-Fend Solutions (D-Fend), an industry leader in counter-drone technology, for a purchase price of $1.5 billion. Wilson Sonsini Goodrich & Rosati advised Centerview Partners LLC, the financial advisor to Motorola Solutions, on the transaction.
D-Fend’s field proven technology is trusted by government, public safety, and enterprise organizations, with thousands of deployments across more than 30 countries, with annual revenue growth of over 50 percent over the last three years and expected full year 2026 revenues of $185 million. The acquisition is expected to close in the fourth quarter of 2026, subject to required regulatory approvals and satisfaction of other customary closing conditions.
The Wilson Sonsini team that advised Centerview Partners on the transaction includes Doug Schnell, Rich Mullen, Nikkisha Smith Howard, and Hayden Smith.
For more information, please see Motorola Solutions’ news release.
D-Fend’s field proven technology is trusted by government, public safety, and enterprise organizations, with thousands of deployments across more than 30 countries, with annual revenue growth of over 50 percent over the last three years and expected full year 2026 revenues of $185 million. The acquisition is expected to close in the fourth quarter of 2026, subject to required regulatory approvals and satisfaction of other customary closing conditions.
The Wilson Sonsini team that advised Centerview Partners on the transaction includes Doug Schnell, Rich Mullen, Nikkisha Smith Howard, and Hayden Smith.
For more information, please see Motorola Solutions’ news release.
Client Highlights
6.02.26
Wilson Sonsini Advises Contentful on Acquisition by Salesforce
On June 1, 2026, Salesforce, the world's No. 1 AI CRM, announced that it has signed a definitive agreement to acquire Contentful, a leading composable content platform trusted by over 4,800 of the world’s leading brands to deliver personalized digital experiences at scale. Wilson Sonsini Goodrich & Rosati advised Contentful on the transaction.
Client Highlights
6.01.26
Firm Advises Edgewise Therapeutics on Its Sale of Sevasemten for up to $2.65 Billion
On June 1, 2026, Edgewise Therapeutics, a leading muscle disease biopharmaceutical company, announced that it has entered into a definitive agreement under which Servier, an independent international pharmaceutical group governed by a foundation, will acquire sevasemten, an orally administered fast skeletal myosin inhibitor in late-stage clinical trials in Becker and Duchenne muscular dystrophies, and Edgewise's muscular dystrophy business for $1.55 billion in upfront cash consideration and up to $1.1 billion in additional milestone payments, for aggregate potential consideration of up to $2.65 billion. The transaction strengthens Edgewise’s balance sheet, providing enhanced financial flexibility and sharpening the company’s strategic focus to accelerate and unlock the full potential of its cardiovascular pipeline. Wilson Sonsini Goodrich & Rosati advised Edgewise on the transaction.
Blog Posts
6.01.26
SEC Proposes to Rescind Climate Disclosure Rules
On May 29, 2026, the U.S. Securities and Exchange Commission issued a proposal to rescind, in its entirety, the climate disclosure rules it adopted in March 2024. While the Commission’s proposal contemplates complete rescission of the climate disclosure rules, it also solicits comment on potential alternatives short of full rescission.